Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $1.8 million.

  • Nephros' Cost of Revenue rose 3506.21% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year increase of 2490.05%. This contributed to the annual value of $5.4 million for FY2024, which is 675.47% down from last year.
  • As of Q3 2025, Nephros' Cost of Revenue stood at $1.8 million, which was up 3506.21% from $1.6 million recorded in Q2 2025.
  • Over the past 5 years, Nephros' Cost of Revenue peaked at $1.8 million during Q3 2025, and registered a low of $991000.0 during Q2 2021.
  • Its 5-year average for Cost of Revenue is $1.4 million, with a median of $1.4 million in 2024.
  • Per our database at Business Quant, Nephros' Cost of Revenue soared by 4682.14% in 2022 and then tumbled by 1582.6% in 2024.
  • Nephros' Cost of Revenue (Quarter) stood at $1.2 million in 2021, then dropped by 15.54% to $1.0 million in 2022, then increased by 17.54% to $1.2 million in 2023, then grew by 13.14% to $1.4 million in 2024, then skyrocketed by 32.54% to $1.8 million in 2025.
  • Its last three reported values are $1.8 million in Q3 2025, $1.6 million for Q2 2025, and $1.7 million during Q1 2025.